Urinary N-acetyl-β-D-glucosaminidase (NAG) in lupus nephritis and rheumatoid arthritis

被引:18
|
作者
Erdener, D [1 ]
Aksu, K
Biçer, I
Doganavsargil, E
Kutay, FZ
机构
[1] Ege Univ Sch Med, Dept Clin Biochem, TR-35100 Izmir, Turkey
[2] Ege Univ Sch Med, Dept Rheumatol, Izmir, Turkey
[3] Ege Univ Sch Med, Dept Biochem, Izmir, Turkey
关键词
N-acetyl-beta-D-glucosaminidase; proteinuria; lupus nephritis; rheumatoid arthritis;
D O I
10.1002/jcla.20073
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Increased activity of urinary N-acetyl-beta-D-glucosaminidase (NAG) can be used as an early indicator of damage to the tubular epithelium. Systemic lupus erythematosus (SLE) is a multisystem autoimmune rheumatic disease. Nephritis is known as the most serious complication of SLE and the strongest predictor of poor outcome. In this study urinary NAG excretion was investigated in 24 SLE patients with normal renal function (serum creatinine <= 1.2 mg/dL) and the results were compared with those from 26 untreated patients with rheumatoid arthritis (RA) and 27 healthy controls. The SLE patients were divided into two groups according to their urinary total protein levels: group A consisted of 16 patients with <= 3.5 g/day proteinuria, and group B consisted of eight patients with nephrotic-range proteinuria (>3.5 g/day). Serum and urinary creatinine, total urinary protein levels, and urinary NAG excretion were measured in patients with SLE and RA. In addition, serum C3 and C4 levels were determined in the SLE patients. Renal biopsies were performed in all of the SLE patients. Glomerular lesions were classified according to WHO criteria for lupus nephritis (LN) I-V. The Systemic Lupus Erythematosus Disease Activity Index (SLEDAI) was used to assess disease activity. Urinary NAG excretion was significantly higher in the SLE groups than in the healthy controls (P<0.001). In urinary NAG excretion there was also significant difference between SLE groups and RA patients (P<0.001). However, there was no significant difference in NAG excretion between the RA and control groups (P=0.062). Urinary NAG excretion was significantly higher (P<0.05) in group B compared to group A. There were no differences in SLEDAI scores, ages, and serum creatinine levels between study groups (P=0.601, P=0.285, P=0.669, respectively). Elevated SLEDAI values and hypocomplementemia were detected more often in younger patients (P<0.010, r=-0.529 and P<0.010, r=-0.569, respectively). There was a strong positive correlation between proteinuria and urinary NAG activity (P<0.001, r=0.759). These results suggest that the determination of urinary NAG activity may be a useful supplement to the routine biochemical analysis performed on the urine in cases of SLE.
引用
收藏
页码:172 / 176
页数:5
相关论文
共 50 条
  • [21] Cadmium exposure and urinary N-acetyl-β-D-glucosaminidase: a meta-analysis
    Kawada, Tomoyuki
    ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH, 2017, 24 (12) : 11860 - 11861
  • [22] Urinary level of N-acetyl-β-D-glucosaminidase (NAG) is an indicator reflecting histological tubular lesion in subclinical IgA nephropathy
    Song, JH
    Kim, MJ
    Lee, SW
    Park, GH
    Lee, SW
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2005, 20 : V226 - V226
  • [23] Cadmium exposure and urinary N-acetyl-β-D-glucosaminidase: a meta-analysis
    Tomoyuki Kawada
    Environmental Science and Pollution Research, 2017, 24 : 11860 - 11861
  • [24] N-Acetyl-β-D-glucosaminidase in acute myocardial infarction
    M. Perwaiz Iqbal
    Khawar A Kazmi
    Hasan R Jafri
    Naseema Mehboobali
    Experimental & Molecular Medicine, 2003, 35 : 275 - 278
  • [25] Urinary β-D-glucuronidase and N-acetyl-β-D-glucosaminidase in cisplatin nephrotoxicity in rat
    Mehanovic-Nikolic, J
    JUGOSLOVENSKA MEDICINSKA BIOHEMIJA-YUGOSLAV MEDICAL BIOCHEMISTRY, 2000, 19 (01): : 21 - 24
  • [26] Stabilities of N-acetyl-β-D-glucosaminidase (NAG) isoenzymes in urine:: advantage of NAG isoenzyme B measurement in clinical applications
    Morita, A
    Numata, Y
    Kosugi, Y
    Noto, A
    Takeuchi, N
    Uchida, K
    CLINICA CHIMICA ACTA, 1998, 278 (01) : 35 - 43
  • [27] Analysis of glycosuria in okapi (Okapia johnstoni): Examination of urinary N-acetyl-β-D-glucosaminidase
    Kawasaki, Ryuta
    Azumano, Akinori
    Ueda, Miya
    Tanaka, Souhei
    Yokota, Aya
    Katoh, Kazuo
    Hagino, Akihiko
    ANIMAL SCIENCE JOURNAL, 2014, 85 (10) : 910 - 914
  • [28] Urinary N-acetyl-β-d-glucosaminidase levels in patients with laryngeal squamous cell carcinoma
    Oektem, Fatih
    Yazicilar, Osman
    Guevenc, Gueven
    Toprak, Murat
    Uzun, Hafize
    Aydin, Seval
    Uslu, Ezel
    JOURNAL OF OTOLARYNGOLOGY, 2007, 36 (04): : 233 - 239
  • [29] Expression modes of urinary N-acetyl-β-D-glucosaminidase in patients with chronic renal insufficiency
    Tassi, C
    Mancuso, F
    Feligioni, L
    Marangi, M
    Capodicasa, E
    CLINICA CHIMICA ACTA, 2004, 346 (02) : 129 - 133
  • [30] The clinical value of urinary N-acetyl-β-D-glucosaminidase levels in childhood age group
    Kavukçu, S
    Soylu, A
    Türkmen, M
    ACTA MEDICA OKAYAMA, 2002, 56 (01) : 7 - 11